Clinical Trial Update: The Effects of RFA in Combination With Second-line Chemotherapy and Bevacizumab on Unresectable CRLM [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update investigating radiofrequency ablation combined with second-line chemotherapy and bevacizumab for unresectable colorectal liver metastases,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Colorectal Neoplasms Malignant

Drugs mentioned

• Bevacizumab (bevacizumab)
• Chemotherapy (second-line)
• Radiofrequency ablation (radiofrequency energy)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Colorectal Neoplasms Malignant | Phase 2, Phase 3 | Status: UNKNOWN